Herantis Pharma Oyj (HEL:HRTIS)

Herantis Pharma Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61	31	32	28	27	40
Market Cap Growth	85.10%	-3.81%	13.79%	4.72%	-34.19%	-21.79%
Enterprise Value	57	27	31	25	26	39
Last Close Price	2.54	1.51	1.57	1.65	2.28	3.95
PE Ratio	-	-	113.47	-	-	-
Forward PE	-	-	-	-	-	1.42
PB Ratio	34.99	-125.74	6.72	-462.92	-23.37	5.34
P/TBV Ratio	34.99	-	6.72	-	-	5.34
EV/EBIT Ratio	-	-	203.31	-	-	-
Debt / Equity Ratio	0.01	-0.30	0.01	-75.33	-6.43	0.95
Quick Ratio	7.47	4.01	3.38	3.26	2.89	4.67
Current Ratio	8.10	4.06	3.39	3.28	2.91	4.68
Return on Equity (ROE)	-287.85%	-220.33%	12.00%	-	-396.06%	-193.95%
Return on Assets (ROA)	-74.56%	-67.44%	1.49%	-71.39%	-64.41%	-36.70%
Return on Capital (ROIC)	-169.92%	-136.82%	2.09%	-93.60%	-74.22%	-42.30%
Return on Capital Employed (ROCE)	-116.60%	-259.40%	3.20%	-184.60%	-242.00%	-59.70%
Earnings Yield	-8.91%	-16.17%	0.88%	-33.41%	-47.91%	-22.60%
FCF Yield	-	-21.43%	-14.60%	-32.05%	-37.28%	-21.14%
Buyback Yield / Dilution	-17.58%	-17.25%	-17.34%	-43.59%	-38.03%	-26.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.